Literature DB >> 12857759

Characterization of the ectodomain shedding of the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1).

Ishrut Hussain1, Julie Hawkins, Aarti Shikotra, David R Riddell, Andrew Faller, Colin Dingwall.   

Abstract

Generation of the amyloid peptide through proteolytic processing of the amyloid precursor protein by beta- and gamma-secretases is central to the etiology of Alzheimer's disease. beta-secretase, known more widely as the beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), has been identified as a transmembrane aspartic proteinase, and its ectodomain has been reported to be cleaved and secreted from cells in a soluble form. The extracellular domains of many diverse proteins are known to be cleaved and secreted from cells by a process known as ectodomain shedding. Here we confirm that the ectodomain of BACE1 is secreted from cells and that this processing is up-regulated by agents that activate protein kinase C. A metalloproteinase is involved in the cleavage of BACE1 as hydroxamic acid-based metalloproteinase inhibitors abolish the release of shed BACE1. Using potent and selective inhibitors, we demonstrate that ADAM10 is a strong candidate for the BACE1 sheddase. In addition, we show that the BACE1 sheddase is distinct from alpha-secretase and, importantly, that inhibition of BACE1 shedding does not influence amyloid precursor protein processing at the beta-site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857759     DOI: 10.1074/jbc.M304186200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1.

Authors:  Lujia Zhou; Lucia Chávez-Gutiérrez; Katrijn Bockstael; Ragna Sannerud; Wim Annaert; Patrick C May; Eric Karran; Bart De Strooper
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 2.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 3.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

4.  RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro.

Authors:  Andrea Rentmeister; Anke Bill; Tina Wahle; Jochen Walter; Michael Famulok
Journal:  RNA       Date:  2006-08-03       Impact factor: 4.942

5.  Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort.

Authors:  Mary J Savage; Daniel J Holder; Guoxin Wu; June Kaplow; Judith A Siuciak; William Z Potter
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Chaperone-like properties of the prodomain of TNFalpha-converting enzyme (TACE) and the functional role of its cysteine switch.

Authors:  Jennifer D Leonard; Frank Lin; Marcos E Milla
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

7.  Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.

Authors:  David R Taylor; Edward T Parkin; Sarah L Cocklin; James R Ault; Alison E Ashcroft; Anthony J Turner; Nigel M Hooper
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

Review 8.  The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.

Authors:  Robert Vassar; Dora M Kovacs; Riqiang Yan; Philip C Wong
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

9.  Identification of beta-secretase (BACE1) substrates using quantitative proteomics.

Authors:  Matthew L Hemming; Joshua E Elias; Steven P Gygi; Dennis J Selkoe
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.